Eikon Therapeutics, Inc. (EIKN) Live Share Price, Invest From India

Eikon Therapeutics, Inc. Stock Performance

as on October 17, 2026 at 2:16 pm IST

Day's Low
Day's High
$7.18
Day's Price Range
$7.76
$7.42
3.23%
Downside
4.58%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$7.42
100.00%
Downside
-100.00%
Upside

Eikon Therapeutics, Inc. share price movements today

Previous Close: $7.54
Open: $7.73
Volume: 459.6K
Market Cap: $408.4M
Day's Low - High: $7.18 - $7.76

Eikon Therapeutics, Inc. Historical Returns

1 Month Return: -13.72 %
3 Month Return: -24.05 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Eikon Therapeutics, Inc. Stock Fundamentals & Key Indicators

Check Eikon Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$408.4M

EPS (TTM)

-4.63

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.63

Industry PE ratio

-6.86

PEG Ratio

0.02

EBITDA

-297.1M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

193.43%

Eikon Therapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Eikon Therapeutics, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Eikon Therapeutics, Inc.	StrongBuy	$408.4M	NA	-1.63	0.00%	0.00%
Moderna	Neutral	$94.4B	-32.76%	-29.64	-12.57%	0.00%
Vertex Pharmaceuticals	StrongBuy	$128.9B	174.93%	29.37	86.04%	0.00%
Regeneron	Buy	$80.1B	42.93%	19.01	84.86%	0.46%

Analyst Recommendation on Eikon Therapeutics, Inc. Stock

Based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for Eikon Therapeutics, Inc.. Average target price of $31

Eikon Therapeutics, Inc. Share Price Target

Get share price movements and forecasts by analysts on Eikon Therapeutics, Inc..

Current Price

$7.42

Analyzed by

3 Analysts

High

$32

Low

$29

Eikon Therapeutics, Inc. target price $0, a slight upside of 0% compared to current price of $7.42. According to 3 analysts rating.

Indian Investors' Interest in Eikon Therapeutics, Inc. Stock

Search interest for Eikon Therapeutics, Inc. Stock has decreased by -35% in the last 30 days, reflecting a downward trend in search activity.

Time period: September 18, 2026 to October 18, 2026

Change:-35% versus previous 30 day period

Eikon Therapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	-
Gross Profit	-	-5	-5	-5
Operating Income	-74	-83	-87	-93
EBITDA	-56	-74	-77	-88
Interest Expense	-	-	-	-
Depreciation	6	5	5	5
Income Before Tax	-71	-79	-82	-88
Income Tax Expense	-	-	-	-
Net Income	-71	-79	-82	-88
Net Profit Margin	0.00%	0.00%	0.00%	0.00%

Eikon Therapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2025
Total Revenue	-
Gross Profit	-24
Operating Income	-338
EBITDA	-299
Interest Expense	0
Depreciation	24
Income Before Tax	-324
Income Tax Expense	-
Net Income	-324
Net Profit Margin	0.00%

Eikon Therapeutics, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-71	-79	-82	-88
Operating Cash Flow	-59	-41	-89	-64
Investing Cash Flow	27	40	-203	46
Financing Cash Flow	0	1	349	0
Change in Cash	-31	0	56	-18

Eikon Therapeutics, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2025
Net Income	-324
Operating Cash Flow	-188
Investing Cash Flow	-181
Financing Cash Flow	352
Change in Cash	-17

Global Institutional Holdings in Eikon Therapeutics, Inc.

Check out the Institutions with significant holdings in Eikon Therapeutics, Inc..

Funds	Holdings
iShares	2.23%
Vanguard	1.94%
Felix Baker	1.03%
AB CAP FUND, INC.	0.91%
Stephen A. Schwarzman	0.31%

See all

Insights on Eikon Therapeutics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NEGATIVE IMPACT
Price Dip
In the last 1 month, EIKN stock has moved down by -13.7%

About Eikon Therapeutics, Inc.

Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established in 2019 and headquartered in Millbrae, California, operating within the United States. The company is dedicated to developing groundbreaking medicines to address significant unmet medical needs. It utilizes a proprietary platform capable of precisely characterizing protein interactions inside living cells. Eikon's drug pipeline includes EIK1001, a systemically delivered TLR 7/8 dual-agonist designed to activate both innate and adaptive anti-cancer immune responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors for ovarian, breast, prostate, and pancreatic cancers. Notably, EIK1004 is brain-penetrant, offering a therapeutic approach for brain metastases and primary brain malignancies. Additionally, EIK1005 is a potent WRN helicase inhibitor and anti-tumor agent aimed at MSI-high tumors, alongside EIK1006.

Organisation	Eikon Therapeutics, Inc.
Headquarters	230 Harriet Tubman Way, Millbrae, CA, 94030, US
Industry	Biotechnology
CEO	Roger Perlmutter

Key Management of Eikon Therapeutics, Inc.

Name	Title
Dr. Roy D. Baynes FACP, M.D., Ph.D.	Executive VP & Chief Medical Officer
Mr. Russ Berman	Chief Technology Officer
Dr. Ching-Pin Chang M.D., Ph.D.	Executive VP & Chief Scientific Officer
Mr. Benjamin Bruno Thorner	Secretary, General Counsel & Chief Business Officer
Ms. Barbara Howes M.B.A.	Chief People Officer
Dr. Roger M. Perlmutter M.D., Ph.D.	Chairman, President & CEO
Mr. Michael A. Klobuchar	Chief Operating Officer
Dr. Robert Tjian Ph.D.	Co-Founder & Member of Scientific Advisory Board
Dr. Eric Betzig Ph.D.	Co-Founder & Member of Scientific Advisory Board
Dr. Alfred Lloyd Bowie Jr., Ph.D.	Treasurer & CFO

FAQs

What is Eikon Therapeutics, Inc. share price today?

Eikon Therapeutics, Inc. share price today is $7.42 as on October 17, 2026 at 8:46 am IST at the close of the market. Eikon Therapeutics, Inc. share today touched a day high of $7.76 and a low of $7.18.

What is the 52 week high and 52 week low for Eikon Therapeutics, Inc. share?

Eikon Therapeutics, Inc. share touched a 52 week high of $0.00 on January 1, 1970 and a 52 week low of $0.00 on January 1, 1970. Eikon Therapeutics, Inc. stock price today i.e. October 17, 2026 at 8:46 am IST is closed at $7.42,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Eikon Therapeutics, Inc.'s market capitalisation today?

Eikon Therapeutics, Inc. market capitalisation is $0.00T as on October 17, 2026 at 8:46 am IST.

How to invest in Eikon Therapeutics, Inc. Stock (EIKN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Eikon Therapeutics, Inc. on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Eikon Therapeutics, Inc. Stock (EIKN) from India?

Indian investors can start investing in Eikon Therapeutics, Inc. (EIKN) shares with as little as ₹94.95999908447266 or $1 (as of October 18, 2026 at 4:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.60 in Eikon Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on October 18, 2026 at 4:41 am IST). Based on Eikon Therapeutics, Inc. share’s latest price of $7.42 as on October 17, 2026 at 8:46 am IST, you will get 1.3477 shares of Eikon Therapeutics, Inc.. Learn more about fractional shares .